Cardiovascular disease (CVD) is a broad category of diseases affecting approximately half of American adults. Despite progress in treatment and management, CVD still has a large health, mortality, and economic burden. This report to Congress describes CVD and its adverse health outcomes, as well as certain risk factors and prevention and treatment options.
American Indian & Alaska Native People (AI-AN)
Reports
Displaying 1 - 10 of 57. 10 per page. Page 1.
Advanced SearchReport to Congress
Report to Congress - The Burden of Cardiovascular Disease in the United States: Patterns and Barriers to Care
ASPE Data Point
National Uninsured Rate at 8.2 Percent in the First Quarter of 2024
Newly released data from the National Health Interview Survey indicate no statistically significant change in the uninsured rate in the first quarter of 2024 from the previous year.
ASPE Issue Brief
Trends in Medicaid and CHIP Telehealth, 2019-2021 Part I: Medicaid and CHIP Telehealth Utilization by Enrollee Characteristics
The COVID-19 pandemic dramatically increased the number of Medicaid and CHIP services delivered via telehealth to all enrollees, regardless of age or race and ethnicity. This Issue Brief examines changes in Medicaid utilization of telehealth services by enrollee characteristics.
ASPE Issue Brief
Health Insurance Coverage and Access to Care among American Indians and Alaska Natives: Recent Trends and Key Challenges
The uninsured rate among non-elderly American Indians and Alaska Natives (AI/ANs) decreased from 32.4 percent in 2010 to 19.9 percent in 2022 – however, the AI/AN population continues to have the highest uninsured rate compared to other racial and ethnic populations.
ASPE Issue Brief
Primary care spending in Medicare fee-for-service: An illustrative analysis using alternative definitions of primary care
This issue brief uses Medicare fee-for-service data to conduct illustrative analyses of primary care spending using a methodology that has been frequently used by policymakers and academics and can be applied to claims data.
ASPE Issue Brief
HealthCare.gov Enrollment by Race and Ethnicity, 2015-2023
This issue brief presents Marketplace enrollment and plan selections by race and ethnicity among 2015-2023 Open Enrollment Period enrollees in HealthCare.gov states using combined self-reported race and ethnicity information with imputed data for missing values.
ASPE Issue Brief
Marketplace Enrollee Demographics, Plan Generosity, and Plan Premiums in HealthCare.gov States, 2015-2022
This Issue Brief focuses on the changes over time in Marketplace insurance coverage in HealthCare.gov states and the association between various demographic and plan characteristics including income, metal level selection, race and ethnicity, and premiums by leveraging self-reported and imputed data.
ASPE Issue Brief
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022
In 2022, 43.3 million Medicare Part D enrollees (82 percent) filled 1.1 billion prescriptions for generic prescription drugs. While most enrollees filled at least one prescription for $2 or less, most (54 percent) paid more than $2 for at least one generic drug. Over 6 million enrollees filled at least one prescription for over $20.
Database, Dataset
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community Survey
State and Local Estimates of the Uninsured Population in the U.S. Using the Census Bureau’s 2022 American Community SurveyMethodological Description
Fact Sheet, Report
Inflation Reduction Act Research Series: Understanding Development and Trends in Utilization and Spending for Drugs Selected Under the Medicare Drug Price Negotiation Program
The Inflation Reduction Act (IRA) authorizes the Secretary of the Department of Health and Human Services (HHS) to negotiate prices directly with participating manufacturers for selected drugs that are high expenditure, single source drugs without generic or biosimilar competition.